Results 281 to 290 of about 177,505 (309)

Ki67 assessment in invasive luminal breast cancer: a comparative study between different scoring methods

Histopathology, 2022
Ayat G Lashen, Andrew Green, Nigel Mongan   +2 more
exaly  

Ki67 : comment l’évaluer ?

Annales de Pathologie, 2011
openaire   +1 more source

Clinical validity and clinical utility of Ki67 in early breast cancer

Therapeutic Advances in Medical Oncology, 2022
Hans H Kreipe, Nadia Harbeck, Matthias Christgen   +2 more
exaly  

Ki67 : quand l’utiliser ?

Annales de Pathologie, 2011
openaire   +1 more source

An interobserver reproducibility analysis of size-set semiautomatic counting for Ki67 assessment in breast cancer

Breast, 2020
Hong Bu
exaly  

Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial

Annals of Oncology, 2013
Wolfgang D Schmitt
exaly  

Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study

British Journal of Cancer, 2015
György Lang, Viktoria Laszlo, Michael Grusch   +2 more
exaly  

Ki67 as a marker of recurrence in craniopharyngioma

Endocrine Abstracts, 2018
Martinez Ortega Antonio Jesus, Venegas Moreno Eva Maria, Dios Fuentes Maria Elena, Remon Ruiz Pablo Jesus, Marquez Rivas Francisco Javier, Ariel Kaen, Ruiz-Valdepenas Eugenio Cardenas, Cano Gonzalez Antonio David, Soto Moreno Alfonso Manuel   +8 more
openaire   +1 more source

Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma

British Journal of Cancer, 2015
Roman Rouzier, Fabien Reyal
exaly  

KI67 expression of melanocytic tumours

Melanoma Research, 1997
A Vajda, L Fuzesi, A Noebel
openaire   +1 more source